Prefer in VTE Prevention of Thromboembolic Events – European Registry in Venous Thromboembolism
To assess the 12 month direct health care resource use and estimated costs following acute first-time (initial) or recurrent VTE
Multi –national, multi-centre, prospective observational disease registry
Dr Petra Laeis, Munich
Dr. Matt Reed
1. Ambulatory Device, Rocket Pleural vent insertion
2. Standard Treatment, Aspiration +/- chest drain
Primary Outcome Measures
To assess whether use of an ambulatory device (Rocket Pleural Vent) and treatment strategy reduces hospital stay. Total length of stay in hospital up to 30 days post randomisation. Up to 30 days post randomisation.
RAMPP trial - Randomised Controlled Trial: Pleural vent (rocket) V standard care in Primary Spontaneous Pnuemothorax
Evaluating the role of early CT Coronary Angiography on patients with suspected or confirmed Acute Coronary Syndrome.
Evaluating the role of early CT Coronary Angiography